Skip to main content
SpringerLink
Log in
Book cover

Using Central Neuromodulators and Psychological Therapies to Manage Patients with Disorders of Gut-Brain Interaction pp 41–87Cite as

A Psychopharmacology Guide by Psychiatrists for Non-psychiatrists

  • Chapter
  • First Online:

  • 470 Accesses

Abstract

Non-psychiatric providers are increasingly called upon to provide medical treatment for their patients suffering from neuropsychiatric illnesses. If pharmacotherapy is elected as a mode of treatment, this chapter will aid clinicians in selecting the most appropriate medication. The choice of medication requires that the provider consider the patient’s medical comorbidities as well as any other medications that the patient may be taking to avoid untoward iatrogenic adverse events. An appreciation of potential side effects related to the various types of medications commonly prescribed to address psychiatric conditions is also imperative and outlined in the chapter.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Health Quality Ontario. Psychotherapy for major depressive disorder and generalized anxiety disorder: a health technology assessment. Ont Health Technol Assess Ser. 2017;17(15):1–167.

    Google Scholar 

  2. Kvam S, Kleppe CL, Nordhus IH, Hovland A. Exercise as a treatment for depression: a meta-analysis. J Affect Disord. 2016;202:67–86.

    Article  PubMed  Google Scholar 

  3. Liu B, Zhang Y, Zhang L, Li L. Repetitive transcranial magnetic stimulation as an augmentative strategy for treatment-resistant depression, a meta-analysis of randomized, double-blind and sham-controlled study. BMC Psychiatry. 2014;14:342.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Huffman JC, Alpert JE. An approach to the psychopharmacologic care of patients: antidepressants, antipsychotics, anxiolytics, mood stabilizers, and natural remedies. Med Clin North Am. 2010;94(6):1141–60.

    Article  CAS  PubMed  Google Scholar 

  5. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Benich JJ 3rd, Bragg SW, Freedy JR. Psychopharmacology in primary care settings. Prim Care. 2016;43(2):327–40.

    Article  PubMed  Google Scholar 

  7. Taylor DM, Barnes TRE, Young AH. The Maudsley prescribing guidelines in psychiatry. 13th ed. Hoboken: Wiley; 2018.

    Google Scholar 

  8. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.

    Article  PubMed  Google Scholar 

  9. Fava GA, Benasi G, Lucente M, Offidani E, Cosci F, Guidi J. Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review. Psychother Psychosom. 2018;87(4):195–203.

    Article  PubMed  Google Scholar 

  10. Teply RM, Packard KA, White ND, Hilleman DE, DiNicolantonio JJ. Treatment of depression in patients with concomitant cardiac disease. Prog Cardiovasc Dis. 2016;58(5):514–28.

    Article  PubMed  Google Scholar 

  11. Qaseem A, Barry MJ, Kansagara D, Clinical Guidelines Committee of the American College of Physicians. Nonpharmacologic versus pharmacologic treatment of adult patients with Major depressive disorder: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;164(5):350–9.

    Article  PubMed  Google Scholar 

  12. Bentley SM, Pagalilauan GL, Simpson SA. Major depression. Med Clin North Am. 2014;98(5):981–1005.

    Article  PubMed  Google Scholar 

  13. Jing E, Straw-Wilson K. Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: a narrative literature review. Ment Health Clin. 2016;6(4):191–6.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Elmaadawi AZ, Singh N, Reddy J, Nasr SJ. Prescriber’s guide to using 3 new antidepressants: vilazodone, levomilnacipran, vortioxetine. Curr Psychiatr Ther. 2015;14(2):28–9, 32–6.

    Google Scholar 

  15. Stahl SM. Stahl’s essential psychopharmacology. 4th ed. New York: Cambridge University Press; 2013.

    Google Scholar 

  16. Olfson M, King M, Schoenbaum M. Benzodiazepine use in the United States. JAMA Psychiat. 2015;72(2):136–42.

    Article  Google Scholar 

  17. Metzler DH, Mahoney D, Freedy JR. Anxiety disorders in primary care. Prim Care. 2016;43(2):245–61.

    Article  PubMed  Google Scholar 

  18. Bastien CH, LeBlanc M, Carrier J, Morin CM. Sleep EEG power spectra, insomnia, and chronic use of benzodiazepines. Sleep. 2003;26(3):313–7.

    Article  PubMed  Google Scholar 

  19. Riemann D, Baglioni C, Bassetti C, Bjorvatn B, Dolenc Groselj L, Ellis JG, Espie CA, Garcia-Borreguero D, Gjerstad M, Gonçalves M, Hertenstein E, Jansson-Fröjmark M, Jennum PJ, Leger D, Nissen C, Parrino L, Paunio T, Pevernagie D, Verbraecken J, Weeß HG, Wichniak A, Zavalko I, Arnardottir ES, Deleanu OC, Strazisar B, Zoetmulder M, Spiegelhalder K. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675–700.

    Article  PubMed  Google Scholar 

  20. Bakken MS, Engeland A, Engesæter LB, Ranhoff AH, Hunskaar S, Ruths S. Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study. Eur J Clin Pharmacol. 2014;70(7):873–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Zhong G, Wang Y, Zhang Y, Zhao Y. Association between benzodiazepine use and dementia: a meta-analysis. PLoS One. 2015;10(5):e0127836.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert AS. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ. 2015;350:h2698.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ekström MP, Bornefalk-Hermansson A, Abernethy AP, Currow DC. Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study. BMJ. 2014;348:g445.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Atkin T, Comai S, Gobbi G. Drugs for insomnia beyond benzodiazepines: pharmacology, clinical applications, and discovery. Pharmacol Rev. 2018;70(2):197–245.

    Article  CAS  PubMed  Google Scholar 

  25. Wilt TJ, MacDonald R, Brasure M, Olson CM, Carlyle M, Fuchs E, Khawaja IS, Diem S, Koffel E, Ouellette J, Butler M, Kane RL. Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the American College of Physicians. Ann Intern Med. 2016;165(2):103–12.

    Article  PubMed  Google Scholar 

  26. Rickels K. Buspirone in clinical practice. J Clin Psychiatry. 1990;51(Suppl):51–4.

    PubMed  Google Scholar 

  27. Schatzberg AF, Nemeroff CB. The American Psychiatric Association publishing textbook of psychopharmacology. 5th ed. Arlington: American Psychiatric Association Publishing; 2017.

    Book  Google Scholar 

  28. Simons P, Cosgrove L, Shaughnessy AF, Bursztajn H. Antipsychotic augmentation for major depressive disorder: a review of clinical practice guidelines. Int J Law Psychiatry. 2017;55:64–71.

    Article  PubMed  Google Scholar 

  29. Jones E, Major B, Fear C. Schizophrenia in a primary care setting. Curr Psychiatry Rep. 2015;17:84.

    Article  PubMed  Google Scholar 

  30. de Silva VA, Suraweera C, Ratnatunga SS, Dayabandara M, Wanniarachchi N, Hanwella R. Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis. BMC Psychiatry. 2016;16(1):341.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Warnez S, Alessi-Severini S. Clozapine: a review of clinical practice guidelines and prescribing trends. BMC Psychiatry. 2014;14:102.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Miller TH. Bipolar disorder. Prim Care. 2016;43:269–84.

    Article  PubMed  Google Scholar 

  33. Brenner CJ, Shyn SI. Diagnosis and management of bipolar disorder in primary care: a DSM-5 update. Med Clin N Am. 2014;98:1025–48.

    Article  PubMed  Google Scholar 

  34. Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck PE Jr, Lewis L, McElroy SL, Post RM, Rapport DJ, Russell JM, Sachs GS, Zajecka J. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000;157(11):1873–5.

    Article  CAS  PubMed  Google Scholar 

  35. Nassir Ghaemi S, Miller CJ, Berv DA, Klugman J, Rosenquist KJ, Pies RW. Sensitivity and specificity of a new bipolar spectrum diagnostic scale. J Affect Disord. 2005;84(2–3):273–7.

    Article  CAS  PubMed  Google Scholar 

  36. Bromley RL, Baker GA. Fetal antiepileptic drug exposure and cognitive outcomes. Seizure. 2017;44:225–31.

    Article  PubMed  Google Scholar 

  37. Beach SR, Kostis WJ, Celano CM, Januzzi JL, Ruskin JN, Noseworthy PA, Huffman JC. Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation. J Clin Psychiatry. 2014;75(5):e441–9.

    Article  PubMed  Google Scholar 

  38. Beach SR, Celano CM, Noseworthy PA, Januzzi JL, Huffman JC. QTc prolongation, torsades de pointes, and psychotropic medications. Psychosomatics. 2013;54(1):1–13.

    Article  PubMed  Google Scholar 

  39. Hemeryck A, Lefebvre RA, De Vriendt C, Belpaire FM. Paroxetine affects metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers. Clin Pharmacol Ther. 2000;67(3):283–91.

    Article  CAS  PubMed  Google Scholar 

  40. Morrato EH, Druss B, Hartung DM, Valuck RJ, Allen R, Campagna E, Newcomer JW. Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs. Arch Gen Psychiatry. 2010;67(1):17–24.

    Article  PubMed  Google Scholar 

  41. American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27(2):596–601.

    Article  Google Scholar 

  42. Sadock BJ, Sadock VA, Ruiz P. Kaplan & Sadock’s comprehensive textbook of psychiatry. 10th ed. Philadelphia: Wolters Kluwer; 2017.

    Google Scholar 

  43. Stahl SM. Stahl’s essential psychopharmacology: prescriber’s guide. 6th ed. New York: Cambridge University Press; 2017.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical College of Wisconsin, Department of Psychiatry and Behavioral Medicine, Department of Family and Community Medicine, Milwaukee, WI, USA

    Thomas W. Heinrich

  2. Medical College of Wisconsin, Department of Psychiatry and Behavioral Medicine, Milwaukee, WI, USA

    Julie Ruth Owen & Deepa S. Pawar

Authors
  1. Thomas W. Heinrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julie Ruth Owen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Deepa S. Pawar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas W. Heinrich .

Editor information

Editors and Affiliations

  1. Pleasant Prairie, WI, USA

    W. Harley Sobin

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Heinrich, T.W., Owen, J.R., Pawar, D.S. (2019). A Psychopharmacology Guide by Psychiatrists for Non-psychiatrists. In: Sobin, W. (eds) Using Central Neuromodulators and Psychological Therapies to Manage Patients with Disorders of Gut-Brain Interaction. Springer, Cham. https://doi.org/10.1007/978-3-030-18218-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-18218-2_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-18217-5

  • Online ISBN: 978-3-030-18218-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation